Insider · CIK 0001301173

Cooper Jeffrey H

Reports to the SEC for 4 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001301173

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,941 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−750 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2021-06-08	Sierra Oncology, Inc.Stock Option (Right To Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-06-09	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,061
2019-06-11	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-06-12	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-13	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.8K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2016-06-09	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+77.7K sh	—	—	77,670
2016-01-12	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+17.8K sh	—	—	17,778
2015-07-09	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2015-05-04	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,539
2013-04-30	HUMANIGEN, INCStock Option (right to buy)A Award	Chief Financial Officer	AAward	−60K sh	—	—	60,000
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−6,500 sh	$21.51	−$140K	157,542
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+15K sh	$26.49	+$397K	56,089
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−15K sh	$26.49	−$397K	164,042
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+6,500 sh	$21.51	+$140K	62,589
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−3,750 sh	$14.39	−$54K	153,792
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+3,750 sh	$14.39	+$54K	66,339
2012-05-14	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−25.3K sh	$38.09	−$962K	41,089
2012-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	SVP, Chief Financial Officer	AAward	+985 sh	$19.35	+$19.1K	41,089
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+2,500 sh	$14.39	+$36K	98,140
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+4,864 sh	$17.54	+$85.3K	44,968
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Comon StockM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−4,864 sh	$17.54	−$85.3K	257,214
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+8,708 sh	$17.86	+$156K	95,640
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−42K sh	$17.33	−$727K	215,250
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+25K sh	$21.51	+$538K	123,140
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−8,708 sh	$17.86	−$156K	206,542
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,500 sh	$14.39	−$36K	204,042
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−83K sh	$35.07	−$2.91M	40,104
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−25K sh	$21.51	−$538K	179,042
2012-02-24	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+42K sh	$17.33	+$727K	86,932
2012-01-03	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	262,078
2012-01-03	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−2,500 sh	$34.75	−$86.9K	40,104
2012-01-03	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,500 sh	$14.39	−$36K	42,604
2011-11-01	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	264,578
2011-11-01	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−2,500 sh	$14.39	−$36K	42,604
2011-11-01	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−2,500 sh	$33.26	−$83.1K	40,104
2011-10-31	BMRNBIOMARIN PHARMACEUTICAL INCA Award	SVP, Chief Financial Officer	AAward	+228 sh	$13.23	+$3,015.528	40,104
2011-10-10	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−18.4K sh	—	—	267,078
2011-10-10	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+18.4K sh	$17.54	+$322K	58,255
2011-10-10	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−18.4K sh	$34.00	−$625K	39,876
2011-09-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	SVP, Chief Financial Officer	SSale	−18.4K sh	$32.00	−$588K	39,876
2011-09-28	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+18.4K sh	$17.54	+$322K	58,255

Recent filings

Accepted (ET)
Jul 14
Cooper Jeffrey H0001209191-22-040263
SEC(opens sec.gov)
Jun 94
Cooper Jeffrey H0001209191-21-039095
SEC(opens sec.gov)
Jun 104
Cooper Jeffrey H0001209191-20-035689
SEC(opens sec.gov)
Jun 124
Cooper Jeffrey H0001209191-19-036484
SEC(opens sec.gov)
Jun 144
Cooper Jeffrey H0001209191-18-037785
SEC(opens sec.gov)
Jun 144
Sierra Oncology, Inc.0001209191-17-039874
SEC(opens sec.gov)
Nov 34
Tobira Therapeutics, Inc.0001209191-16-148109
SEC(opens sec.gov)
Jun 134
ProNAi Therapeutics Inc0001209191-16-127392
SEC(opens sec.gov)
Jan 144
Tobira Therapeutics, Inc.0001209191-16-091523
SEC(opens sec.gov)
Jul 134
Tobira Therapeutics, Inc.0001209191-15-060713
SEC(opens sec.gov)
May 64
Tibira Therapeutics, Inc.0001209191-15-039687
SEC(opens sec.gov)
May 24
Cooper Jeffrey H0001181431-13-024866
SEC(opens sec.gov)
May 164
Cooper Jeffrey H0001140361-12-025912
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE

NOVATO, CA, 94949